Moody's and S&P Global noted their downgrades were unusual for the insurance giant and expressed optimism that the company will overcome multiple operational difficulties, Modern Healthcare reported.

2024 UnitedHealth shares fall after medical services costs at the healthcare conglomerate surpass Wall Street expectations for the first time in two years, even as it beats fourth-quarter profit ...

The health care giant has attacked reports that it is under investigation for possible Medicare fraud by the Department of Justice.

UnitedHealth CEO Andrew Witty abruptly stepped down on Tuesday, sending shares down more than 12%. Witty is being replaced by Stephen Hemsley, UnitedHealth's former boss, with immediate effect.

The next two largest U.S. PBMs - UnitedHealth Group's OptumRx and ... slightly below analysts' expectations of $2.33 billion. Lilly in February cut the price for vials of Zepbound by $50 or ...

Kaye said that the company's medical loss ratio in Medicare Part D was also in line with its expectations. Elevance Health's earnings release follows shortly after industry behemoth UnitedHealth ...

Shane joined Newsweek in February 2018 from IBT UK where he held various editorial roles covering different beats ... English. UnitedHealth "did not perform up to our expectations" in the first ...

Investors will be watching closely to see whether UnitedHealth can maintain its streak of earnings beats, especially in the face of sector-wide cost concerns and regulatory scrutiny. An analysis ...

UnitedHealth Group subsidiary UnitedHealthcare, the Medicare Advantage market leader, made the greatest gains among its peers in Dual Eligible Special Needs Plan membership. Humana, the No. 2 ...